STC Partners to start new resi project in Bucharest

Business Forum
STC Partners will start a new residential project in Bucharest after completing the acquisition of a land plot for €7.2 million.

The developer has already secured the building permit for the new residential complex that will feature 170 apartments, retail spaces and additional facilities for residents. The estimated investment in the complex will reach close to €35 million.

“Construction will start in the fall of this year, and the sales are expected to start in the coming weeks, as many of our clients, partners, and collaborators have already requested offers", says Andrei Ștefan, Partner STC Partners. 

At present, STC Partners is developing the second phase of a separate residential project in Bucharest.

RECOMMENDED
Fewer homes get completed in Romania in Q1-Q3 2024
Real estate

Fewer homes get completed in Romania in Q1-Q3 2024

The total number of homes completed in Romania in the first nine months of the year was 42,312, down by 18.1% compared to the same period last year, according to a report by the National Institute of Statistics (INS).

Northern Bucharest to continue to drive resi demand
Real estate

Northern Bucharest to continue to drive resi demand

Victor Terheș, Sales Director at Bellemonde, talked to Property Forum about the status of its €40 million residential investment in northern Bucharest and the growing demand for homes in this area in the long term.

RECOMMENDED FROM THE HOME PAGE
IFC to acquire 10% stake in Romanian pension firm Carpathia
Finance

IFC to acquire 10% stake in Romanian pension firm Carpathia

The International Finance Corporation (IFC), a member of the World Bank Group, has signed an agreement with Vienna Insurance Group (VIG) to acquire approximately 10% of the shares of Carpathia Pensii, a Romanian private pension company.

Industry

Polpharma to launch takeover bid for Biofarm

Polish pharmaceutical company Zakłady Farmaceutyczne Polpharma has agreed to launch a voluntary public takeover offer (VTO) for all shares of Romanian drugmaker Biofarm, according to a regulatory filing.

READ MORE
Business Forum  |  8 May, 2026 at 7:03 PM
Business Forum  |  8 May, 2026 at 6:00 PM